Crossref
In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy
International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e12
DOI: 10.1016/j.ijrobp.2026.02.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von P. Suryadevara.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Suryadevara, P. (2026). In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy. International Journal of Radiation Oncology*Biology*Physics, 125(1), e12. https://doi.org/10.1016/j.ijrobp.2026.02.026
Vancouver
Suryadevara P. In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e12. doi:10.1016/j.ijrobp.2026.02.026
BibTeX
@article{Suryadevara2026,
author = {Suryadevara, P.},
title = {In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {125},
number = {1},
pages = {e12},
doi = {10.1016/j.ijrobp.2026.02.026}
}
EUVIMED